Skip to main content

Advertisement

SpringerLink
Log in

Cancer in pregnancy. Part II: treatment options of breast and other non-gynecological malignancies

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

In case of non-gynecological solid tumors and hematological malignancies diagnosed during pregnancy, individual diagnostic and treatment options must be established by an interdisciplinary team.

Methods

In part II of the present review we report on diagnostic and therapeutic principles in distinct entities of solid and hematological malignancies.

Results

On the basis of a review of the current literature, clinical guidelines and algorithms have been established for diagnosis and therapy of maternal cancer during pregnancy.

Conclusions

The prognosis of the malignancy and the patient’s informed consent must be taken into consideration when the well-being of the expectant mother is weighed against the well-being of the unborn child in case of maternal cancer during pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Loibl S (2008) New therapeutic options for breast cancer during pregnancy. Breast Care (Basel) 3(3):171–176

    Google Scholar 

  2. Litton JK, Theriault RL, Gonzalez-Angulo AM (2009) Breast cancer diagnosis during pregnancy. Womens Health (Lond Engl) 5(3):243–249

    Google Scholar 

  3. Loibl S et al (2006) Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 106(2):237–246

    Article  PubMed  Google Scholar 

  4. Pavlidis NA (2000) Cancer and pregnancy. Ann Oncol 11(Suppl 3):247–253

    Article  PubMed  Google Scholar 

  5. Schönborn I (2009) Malignant diseases in pregnancy. Gynakol Geburtsmed Gynakol Endokrinol 5(2):114–125

    Google Scholar 

  6. Bon GG et al (2001) Maternal serum Ca125 and Ca15-3 antigen levels in normal and pathological pregnancy. Fetal Diagn Ther 16(3):166–172

    Article  PubMed  CAS  Google Scholar 

  7. Sarandakou A, Protonotariou E, Rizos D (2007) Tumor markers in biological fluids associated with pregnancy. Crit Rev Clin Lab Sci 44(2):151–178

    Article  PubMed  CAS  Google Scholar 

  8. Azim HA Jr, Peccatori FA, Pavlidis N (2010) Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors. Cancer Treat Rev 36(2):101–109

    Article  PubMed  CAS  Google Scholar 

  9. Barthelmes L et al (2005) Pregnancy and breast cancer. BMJ 330(7504):1375–1378

    Article  PubMed  Google Scholar 

  10. Hahn KM et al (2006) Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107(6):1219–1226

    Article  PubMed  Google Scholar 

  11. Azim HA Jr et al (2011) Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer 47(1):74–83

    Article  PubMed  Google Scholar 

  12. Minsker DH, Manson JM, Peter CP (1993) Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol 121(2):217–223

    Article  PubMed  CAS  Google Scholar 

  13. Stensheim H (2009) Malignant melanoma and pregnancy. Onkologie 32(12):715–716

    Article  PubMed  Google Scholar 

  14. O’Meara AT et al (2005) Malignant melanoma in pregnancy. A population-based evaluation. Cancer 103(6):1217–1226

    Article  PubMed  Google Scholar 

  15. Silipo V et al (2006) Malignant melanoma and pregnancy. Melanoma Res 16(6):497–500

    Article  PubMed  Google Scholar 

  16. Gottschalk N et al (2009) Advanced metastatic melanoma during pregnancy: a multidisciplinary challenge. Onkologie 32(12):748–751

    Article  PubMed  Google Scholar 

  17. Erfurt-Berge C, Kaempgen E (2010) Melanoma and pregnancy. Hautarzt 61(12):1040–1045

    Article  PubMed  CAS  Google Scholar 

  18. Hauschild A et al (2008) Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion. Cancer 112(5):982–994

    Article  PubMed  CAS  Google Scholar 

  19. Pages C et al (2010) Management and outcome of metastatic melanoma during pregnancy. Br J Dermatol 162(2):274–281

    Article  PubMed  CAS  Google Scholar 

  20. Kodama I et al (1997) Gastric cancer during pregnancy. Kurume Med J 44(3):179–183

    Article  PubMed  CAS  Google Scholar 

  21. Ueo H et al (1991) Prognosis in gastric cancer associated with pregnancy. World J Surg 15(2):293–297 (discussion 298)

    Article  PubMed  CAS  Google Scholar 

  22. Bruggmann D et al (2006) Gastric cancer in pregnancy—a case report. Zentralbl Gynakol 128(4):224–228

    Article  PubMed  CAS  Google Scholar 

  23. Kakoza RM et al (2009) Pancreatic adenocarcinoma in the pregnant patient: a case report and literature review. J Gastrointest Surg 13(3):535–541

    Article  PubMed  Google Scholar 

  24. Ikuta S et al (2008) Large mucinous cystic neoplasm of the pancreas associated with pregnancy. World J Gastroenterol 14(47):7252–7255

    Article  PubMed  Google Scholar 

  25. Wiseman JE et al (2008) Cystic pancreatic neoplasm in pregnancy: a case report and review of the literature. Arch Surg 143(1):84–86

    Article  PubMed  Google Scholar 

  26. Hakamada K et al (2008) Anaplastic carcinoma associated with a mucinous cystic neoplasm of the pancreas during pregnancy: report of a case and a review of the literature. World J Gastroenterol 14(1):132–135

    Article  PubMed  Google Scholar 

  27. Blackbourne LH et al (1997) Pancreatic adenocarcinoma in the pregnant patient: case report and review of the literature. Cancer 79(9):1776–1779

    Article  PubMed  CAS  Google Scholar 

  28. Cobey FC, Salem RR (2004) A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 187(2):181–191

    Article  PubMed  Google Scholar 

  29. Yaghoobi M, Koren G, Nulman I (2009) Challenges to diagnosing colorectal cancer during pregnancy. Can Fam Physician 55(9):881–885

    PubMed  Google Scholar 

  30. Minter A et al (2005) Colon cancer in pregnancy. Cancer Control 12(3):196–202

    PubMed  Google Scholar 

  31. Janssen (2005) Colorectal cancer during pregnancy. Der Gynäkologe 38(2):112–117

    Article  Google Scholar 

  32. Bernstein MA, Madoff RD, Caushaj PF (1993) Colon and rectal cancer in pregnancy. Dis Colon Rectum 36(2):172–178

    Article  PubMed  CAS  Google Scholar 

  33. Erkek B et al (2007) Subsite distribution of colorectal carcinoma and implications for screening; a retrospective audit of 1771 cases. Hepatogastroenterology 54(73):77–80

    PubMed  Google Scholar 

  34. Dahling MT et al (2009) Pregnancy-associated colon and rectal cancer: perinatal and cancer outcomes. J Matern Fetal Neonatal Med 22(3):204–211

    Article  PubMed  Google Scholar 

  35. No authors listed (2010) Chemotherapy of metastatic colorectal cancer. Prescrire Int 19(109): 219–24

    Google Scholar 

  36. Kanate AS, Auber ML, Higa GM (2009) Priorities and uncertainties of administering chemotherapy in a pregnant woman with newly diagnosed colorectal cancer. J Oncol Pharm Pract 15(1):5–8

    Article  PubMed  Google Scholar 

  37. Gensheimer M et al (2009) Administration of oxaliplatin to a pregnant woman with rectal cancer. Cancer Chemother Pharmacol 63(2):371–373

    Article  PubMed  CAS  Google Scholar 

  38. Dessolle L et al (2007) Placental metastases from maternal malignancies: review of the literature. J Gynecol Obstet Biol Reprod (Paris) 36(4):344–353

    CAS  Google Scholar 

  39. Khochikar MV (2010) Management of urological cancers during pregnancy. Nat Rev Urol 7(4):195–205

    Article  PubMed  Google Scholar 

  40. Spahn M et al (2005) Bladder carcinoma during pregnancy. Urol Int 74(2):153–159

    Article  PubMed  CAS  Google Scholar 

  41. Gladman MA et al (2002) Renal cell carcinoma in pregnancy. J R Soc Med 95(4):199–201

    Article  PubMed  CAS  Google Scholar 

  42. Kim PT et al (2006) Laparoscopic adrenalectomy for pheochromocytoma in pregnancy. Can J Surg 49(1):62–63

    PubMed  Google Scholar 

  43. Lew PS et al (2010) Dilemmas in management of brain tumours in pregnancy. Ann Acad Med Singap 39(1):64–65

    PubMed  Google Scholar 

  44. Haas JF, Janisch W, Staneczek W (1986) Newly diagnosed primary intracranial neoplasms in pregnant women: a population-based assessment. J Neurol Neurosurg Psychiatry 49(8):874–880

    Article  PubMed  CAS  Google Scholar 

  45. Sneed PK et al (1995) Fetal dose estimates for radiotherapy of brain tumors during pregnancy. Int J Radiat Oncol Biol Phys 32(3):823–830

    Article  PubMed  CAS  Google Scholar 

  46. Magne N et al (2001) Radiotherapy for a solitary brain metastasis during pregnancy: a method for reducing fetal dose. Br J Radiol 74(883):638–641

    PubMed  CAS  Google Scholar 

  47. Isla A et al (1997) Brain tumor and pregnancy. Obstet Gynecol 89(1):19–23

    Article  PubMed  CAS  Google Scholar 

  48. Ferlito A et al (1998) Pregnancy and malignant neoplasms of the head and neck. Ann Otol Rhinol Laryngol 107(11 Pt 1):991–998

    PubMed  CAS  Google Scholar 

  49. Smith LH et al (2003) Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 189(4):1128–1135

    Article  PubMed  Google Scholar 

  50. Vannucchi G et al (2010) Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol 162(1):145–151

    Article  PubMed  CAS  Google Scholar 

  51. Vini L et al (1999) Management of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol 140(5):404–406

    Article  PubMed  CAS  Google Scholar 

  52. Parlea L et al (2006) Follicular carcinoma of the thyroid with aggressive metastatic behavior in a pregnant woman: report of a case and review of the literature. Hormones (Athens) 5(4):295–302

    Google Scholar 

  53. Roth LK, Taylor HS (2001) Risks of smoking to reproductive health: assessment of women’s knowledge. Am J Obstet Gynecol 184(5):934–939

    Article  PubMed  CAS  Google Scholar 

  54. Pavlidis N (2008) Lung cancer during pregnancy: an emerging issue. Lung Cancer 59(3):279–281

    Article  PubMed  Google Scholar 

  55. Azim HA Jr, Peccatori FA, Pavlidis N (2010) Lung cancer in the pregnant woman: to treat or not to treat, that is the question. Lung Cancer 67(3):251–256

    Article  PubMed  Google Scholar 

  56. Ardizzoni A et al (2007) Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 99(11):847–857

    Article  PubMed  CAS  Google Scholar 

  57. Martin D et al (1997) Rhabdomyosarcoma treated with chemotherapy during the third trimester. Obstet Gynecol 89(5 Pt 2):828–831

    Article  PubMed  CAS  Google Scholar 

  58. Merimsky O et al (1999) Management of cancer in pregnancy: a case of Ewing’s sarcoma of the pelvis in the third trimester. Ann Oncol 10(3):345–350

    Article  PubMed  CAS  Google Scholar 

  59. O’Day MP et al (1994) Orbital rhabdomyosarcoma metastatic to the placenta. Am J Obstet Gynecol 171(5):1382–1383

    PubMed  Google Scholar 

  60. Rizack T et al (2009) Management of hematological malignancies during pregnancy. Am J Hematol 84(12):830–841

    Article  PubMed  Google Scholar 

  61. Pereg D, Koren G, Lishner M (2007) The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy. Haematologica 92(9):1230–1237

    Article  PubMed  Google Scholar 

  62. Azim HA Jr, Pavlidis N, Peccatori FA (2010) Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors. Cancer Treat Rev 36(2):110–121

    Article  PubMed  CAS  Google Scholar 

  63. Aviles A, Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2(3):173–177

    Article  PubMed  CAS  Google Scholar 

  64. Pye SM et al (2008) The effects of imatinib on pregnancy outcome. Blood 111(12):5505–5508

    Article  PubMed  CAS  Google Scholar 

  65. Conchon M et al (2009) Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study. J Hematol Oncol 2:42

    Article  PubMed  Google Scholar 

  66. Shuhaila A et al (2008) Maternal melanoma with placental metastasis. Singap Med J 49(3):e71–e72

    CAS  Google Scholar 

  67. Hoellen F et al (2010) Foetal rhabdomyosarcoma with massive cardiac and placental infiltration associated with intrauterine foetal death. Z Geburtshilfe Neonatol 214(4):167–169

    Article  PubMed  CAS  Google Scholar 

  68. Surbone A, Peccatori F, Pavlidis N (2008) Why is the topic of cancer and pregnancy so important? Why and how to read this book. Recent Results Cancer Res 178:1–2

    Article  PubMed  CAS  Google Scholar 

  69. Pentheroudakis G, Pavlidis N (2006) Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 42(2):126–140

    Article  PubMed  Google Scholar 

  70. Pentheroudakis G (2008) Cancer and pregnancy. Ann Oncol 19(Suppl 5):v38–v39

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Andres J. Schrader, M.D., Ph.D., for helpful comments and critical review of the manuscript.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University Hospital of Schleswig-Holstein, Campus Luebeck, Ratzeburger Allee 160, 23538, Luebeck, Germany

    Friederike Hoellen, Marc Thill, Doerte W. Luedders, Katharina Kelling & Michael K. Bohlmann

  2. Department of Internal Medicine III, Klinikum Grosshadern, Ludwigs-Maximilians-University of Munich, Munich, Germany

    Roland Reibke

  3. Department of Thoracic Surgery, Thoraxklinik, University of Heidelberg, Heidelberg, Germany

    Katrin Hornemann

  4. Department of Obstetrics and Gynecology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany

    Amadeus Hornemann

Authors
  1. Friederike Hoellen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roland Reibke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katrin Hornemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marc Thill
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Doerte W. Luedders
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Katharina Kelling
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Amadeus Hornemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michael K. Bohlmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Friederike Hoellen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoellen, F., Reibke, R., Hornemann, K. et al. Cancer in pregnancy. Part II: treatment options of breast and other non-gynecological malignancies. Arch Gynecol Obstet 284, 1481–1494 (2011). https://doi.org/10.1007/s00404-011-2059-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-011-2059-7

Keywords

Search

Navigation